Introduction
Induction of renal arteriolopathy by cyclosporine (CsA) nephrotoxicity may be augmented by the action of vasoactive molecules mainly vasoconstrictors. Nitric oxide (NO) plays an important role in renal physiology and pathophysiology.
(1) NO was first found in 1987 to be typical with endothelial derived relaxing factor (EDRF) (2) , and this was followed by a quick package of information identifying the significance of NO not only in vascular system and hemodynamics but also in nervous and immune defense systems (3).
Endothelin-1 (ET-1) is the most powerful mammalian vasoconstrictor. In 1990, the document came out to link ET-1 with acute CsA nephrotoxicity. CsA has been found to stimulate ET-1 production in cultured renal epithelial cells and the renal ET receptors have been shown to be amplified in rats with CsA-induced nephrotoxicity.(4) Vascular endothelial growth factor (VEGF) is considered as signal protein of the formation of new blood vessels (5) , it has main role on acute and chronic renal diseases (6, 7) . In late stages of renal disease, down regulation of VEGF expression and increasing of capillaries injury were observed in CsAmediated nephrotoxicity.
Angiotensin II is a well-known growth factor stimulating the activity of fibroblast, leading to deposition of extracellular matrix, and the scarring of tissue. Administration of angiotensin II in rats for a long period induces tubulointerstitial damage. This damage is also observed after chronic CsA administration. (8) The blockade of renin angiotensin system (RAS) in chronic CsA nephropathy by angiotensin converting enzyme inhibitor (ACEI) decreases blood pressure, potentiates vasodilation of afferent arteriole, and ameliorates interstitial fibrosis. (9) Mesenchymal stem cells (MSCs) are proved to be involved in the regeneration of many tissues subjected to different types of injury.(10) Since, bone marrow derived mesenchymal stem cells (BM-MSCs) and adipose tissue derived mesenchymal stem cells (AD-MSCs) have been evaluated in a chronic renal damage model with promising results. AD-MSCs and BM-MSCs sources of MSCs were used to treat the nephrotoxic effects of CsA in this study.
Herein, the focus of our study is to explore the mechanisms behind the therapeutic efficacy of BM-MSCs and AD-MSCs in mitigating nephrotoxicity induced by CsA in rats. In addition, the study was extended to elucidate the role of stem cell versus angiotensin converting enzyme inhibitor in kidney repair. Moreover, introducing awareness for the nephrologists for renal dysfunction due to CsA administration.
Methods
Isolation and preparation of MSCs were established according to Alhadlaq and Mao (11) and Tomiyama, et al., (12) using Dulbecco's modified Eagle's medium (DMEM) (GIBCO/BRL, New York, USA), supplemented with 10% foetal bovine serum (GIBCO/BRL). In addition, to confirm the mesenchymal nature of the isolated cells, in vitro differentiation of bone marrow and adipose derived cells including adipogenesis assay (13) , chondrogenesis assay (14) and osteogenesis assay (15) (8 rats) and two months (8 rats). After deeply anaesthetized using diethyl ether, the rats in the control group as well as in the CsA group were sacrificed after treatment. While, all treated groups divided into two subgroups equally and were sacrificed after one and two months post treatment.
Biochemical Analyses
Serum creatinine and urea were estimated by auto analyzer A15 (Biosystem, Barcelona, Spain). Serum VEGF, ET-1 and endothelial nitric oxide synthase (eNOS) levels were determined according to the manufacturer's instructions by using enzyme-linked immunosorbent assay (ELISA) kits based on the principle of double-antibody sandwich technique, the optical density (OD) was measured under 450 nm wavelength within 10 min after adding the stop solution. The standard curve linear regression equation was calculated, and then OD values of the samples were applied on the regression equation to calculate the corresponding concentration of samples. Kits were purchased from Glory Science Co. (Del Rio, Texas, USA).
Histopathological Investigation
After fixation of kidney samples in 10% formalin saline for twenty-four hours, paraffin wax tissue blocks were prepared for sectioning at 4 microns by microtome. The obtained tissue sections were collected on glass slides, deparaffinized and stained by hematoxylin and eosin (H&E) stains for histopathological examination. (22) Statistical Analysis All results were expressed as Mean±standard deviation (SD). Data were analyzed by one way analysis of variance (ANOVA) using the Statistical Package for the Social Sciences (SPSS) program, version 17 followed by least significant difference (LSD) to compare significance between groups. Difference was considered significant when p-value< 0.05.
Our previous data have shown that, the adherent cells from bone marrow and adipose tissue generated many colonies and displayed a heterogeneous morphology with elongated spindle like shape. Moreover, differentiation of BM-MSCs and AD-MSCs through adipogenesis chondrogenesis and osteogenesis was confirmed by using Alizarin Red S stain, Oil Red O stain and Alcian Blue stain, respectively. (23, 24) Flow cytometry findings showed that BM-MSCs were positive for CD44 (77.1±18.1) and CD105 (78.7±16.3) and negative for CD34 (1.62±0.43). Also, AD-MSCs characterization using flow cytometry showed CD44 positive (81.2±19.6) and CD105 positive (74.3±16.9), but CD34 negative (3.05±0.71). Where, number of samples equal three from each type of MSCs. (17) Results Also, our previous study revealed that the treatment with BM-MSCs, AD-MSCs and ACEI after one and two months evoked significant (p˂0.05) decline in serum creatinine and urea levels paralleled by significant (p˂0.05) elevation in glomerular filtration rate (GFR) value in comparison with CsA group.(17) Table 1 displayed the levels of serum ET-1, VEGF and eNOS in the different studied groups. CsA group showed significant (p˂0.05) rise of serum ET-1 along with significant (p˂0.05) drop of serum VEGF and eNOS levels compare to the control group. However, BM-MSCs, AD-MSCs and ACEI-treated groups showed significant (p˂0.05) changes in serum ET-1, VEGF and eNOS levels as compared to CsA group.
Biochemical Markers
By comparing the data of BM-MSCs, AD-MSCs and ACEI-treated groups after 2 months with those treated after 1 month, it show that there was significant (p˂0.05) increase in serum eNOS level after 2 months of treatment. Meanwhile, there was significant (p˂0.05) decline in serum eNOS leve l of AD-MSCs treated group after 1 month versus that treated with BM-MSCs after 1 month. Treatment with ACEI for 2 months led to significant (p˂0.05) depletion in serum VEGF level versus the groups of rats treated either with ACEI for 1 month or BM-MSCs for 2 months.
Histopathological Findings
Control group showed normal histological organization of the glomeruli and tubules at the cortex ( Figure 1A ). CsA group revealed focal hemorrhage in between the degenerated tubules at the cortex associated with congestion in the cortical blood vessels and perivascular inflammatory cells infiltration ( Figure 1B) . BM-MSCs-treated group (after one month) revealed focal hemorrhage in between the degenerated tubules at the corticomedullary portion associated with congestion in the cortical blood vessels, swelling and vacuolization in the endothelial cells lining the glomerular tufts ( Figure 1C) . After 2 months of treatment with BM-MSCs, congestion in the cortical blood vessels was observed ( Figure 1D ). AD-MSCs-treated group (after one month) revealed mild congestion in the cortical portion ( Figure 1E ). There was no histopathological alteration seen after two months of treatment with AD-MSCs ( Figure 1F ). Treatment with ACEI led to focal hemorrhage and hemolysis between the degenerated tubules in corticomedullary portion after one month ( Figure 1G ) and mild congestion in the cortical blood vessels associated with focal perivascular inflammatory cells aggregation after 2 months ( Figure 1H ). 
Discussion
The positive effects of MSC in animal models of CKD were mentioned lastly, as indicated by the depletion of plasma creatinine levels (25), improvement of proteinuria (26), renal fibrosis (27) , glomerulosclerosis (28) , and renal filtration (29) . Unfortunately, the exact mechanisms behind these reparative processes are presently unknown. The long-term administration of CsA as immunosupressor agent for patients with renal and heart transplantation promote endothelial cell damage through high level of Von Willebrand factor, pselectin, thrombin complexes (30) , and suppress basal and stimulated NO generation resulted in severe vascular disease.(31) CsA could also induce imbalance in the rate of vasodilator to vasoconstrictor in favor of vasoconstriction leading to lowgrade ischemic injury, which is likely associated with CsA nephrotoxicity.(32) Therefore, the decrease in GFR after CsA injection suggests the involvement of vasoconstriction in the mechanism of its nephrotoxicity.
The simultaneous significant elevation in serum creatinine and urea levels in CsA-group versus the control group confirms the later suggestion. CsA has been found to increase ET-1 production from renal epithelial cell culture and the renal ET receptors showed overexpression in rats with nephrotoxicity induced by CsA.(4) The excess production of thromboxane due to CsA is linked with the activated infiltrating platelets and macrophage in kidney tissue, amplification of kidney lipid peroxidation, and generation of ROS with consequent endothelial injury. (33) This supports the study by another study which proved that CsA-induced chronic ischemia is associated with ROS and lipid peroxidation. (34) In addition, the significant attenuation of CsA nephropathy after antioxidants supplementation confirms this idea. (35) The restricted expression of VEGF in glomerular and some tubular cells of adult kidneys confirms its implication in maintaining permeability and integrity of the glomerulus's capillaries. The results of this study showed that serum level of VEGF is significantly reduced in CsA group relative to the control group. This reduction emphasizes the involvement of VEGF in CsAmediated nephrotoxicity. Surprisingly, the mean level of such marker is significantly elevated in serum of rats after treatment with both AD-MSCs and BM-MSCs in a time dependent manner. This elevation may suggest an induction of a vascular protection-related pathway by the inoculated MSC in this study. The essentialities of VEGF in endothelial and vascular system development and in glomerulogenesis confirm our later suggestion.
More evidence in the implication of MSCs in the promotion of angiogenesis is by acting as pericyte-like cells to support the new vasculature and/or secreting molecules strongly associated with the angiogenetic process including VEGF, insulin-like growth factor 1 (IGF-1), hepatocyte growth factor (HGF), placental growth factor (PIGF), monocyte chemoattractant protein-1 (MCP-1), plateletderived growth factor (PDGF) and fibroblast growth factor 2 (FGF-2). (36, 37, 38) A somewhat similar kidneys repair mechanism may be involved in MSCs-treated rats, in our study. This mechanism agrees with the protective role of VEGF against glomerular injury.(29,39) Moreover, the results of Miyamoto, et al., showed that VEGF expression is inversely correlated with the development of glomerulosclerosis in progressive renal diseases necessitate the implication of the latter mechanism. (40) CsA-induced acute renal injury, is believed to be associated with abnormal expression of nitric oxide synthase (NOS). (41) the diseased kidneys cause a sustained afferent arteriolar vasoconstriction. (41) (42) (43) VEGF has been found to induce endothelial NO formation and this mechanism has a favorable impact in maintaining endothelial cell viability (44) , inhibition of vascular inflammation and suppression of the vascular smooth muscle cell activation resulting in preservation of vascular integrity.(5) Meanwhile in this study, not only the serum levels of VEGF but also NOS levels are significantly increased in-group injected with BM-MSCs or AD-MSCs, compared with those in CsA group. These increments might be one of the mechanisms by which these cells can participate to ameliorate CsA-induced nephrotoxicity.
Noteworthy, the serum level of NOS in rats treated with MSCs is negatively correlated with transforming growth factor (TGF)-β level in the same animal groups (data not shown). NOS inhibition in rats via L-arginine analogue leads to increased afferent arterioles construction, which is associated with local activation of RAS and overexpression of TGF-β in the kidneys. (45) In addition, A progressive nephropathy induced by CsA can be modulated by NO stimulation with consequent downregulation of TGF-β expression.(46) Since TGF-β is a key player in the development of renal fibrosis by direct stimulation of extracellular matrix (ECM) components and inhibition of collagenase production, will ultimately resulting in renal scarring (47) , in which one can state that the stimulation of NOS to the suggested mechanisms of kidney repairs by MSCs in the present study.
ET-1 can also disrupt renal architecture due to its impact on ECM accumulation and tubulointerstitial fibrosis. However, both vasoconstriction and afferent arteriolopathy have been shown to be normalized paralleled by improvement of the histological feature of kidney in the groups treated with MSCs particularly AD-MSCs. The normalization of both vasoconstriction and afferent arteriolopathy detected in ACEI, BM-MSCs and AD-MSCstreated groups confirm this suggested mechanism. Also, the disruption of renal architecture and the tubulointerstitial inflammation observed in CsA model and the disappearance of most of these abnormalities after treatment with MSCs add more light to the previous proposed mechanisms.
Another important mechanism on the line of impairing nephrotoxicity induced by CsA involves activation of RAS via hemodynamic pathway. This is mediated by inhibition of angiotensin II which is a causative factor of endothelial cell apoptosis in vitro. (48) This is because of the treatment of rats with ACEI, Lisinopril causes an elevation in the level of eNOS but decreases ET-1 compared with CsAchallenged rats, with a simultaneous improvement in kidney architecture. The vasoconstricting activity which is partially related to the activation of RAS, ET-1 and imbalance in prostaglandins and thromboxane (49) , confirms the possibility of a mechanism based on RAS inhibition to be involved in kidney repair after treatment with Lisinopril.
Conclusion
this study demonstrated that cell therapy elicited angiogenesis and anti-arteriolopathic effects in a rat model of nephropathy induced by CsA. The increment of eNOS and VEGF may be one of the mechanisms underlying the renoprotective properties of mesenchymal stem cell. Moreover, our findings shed more light on the potential rationale for the clinical application of stem cell-based therapy in kidney diseases.
